live attenuated chimeric japanese encephalitis vaccine

Vaccineexperimental

Clinical trial activity

23 trials · 19 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
13
Phase 3
8
Phase 4
8

Earliest trial started Apr 1, 2003 (NCT00981175)

Timeline

2000s

  1. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2005

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2025

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • attenuated japanese encephalitis virus
  • imojev
  • japanese encephalitis live attenuated sa 14-14-2 vaccine
  • je live attenuated sa 14-14-2 vaccine
  • live attenuated chimeric japanese encephalitis vaccine
  • live attenuated chimeric je vaccine
  • live attenuated japanese encephalitis chimeric virus vaccine
  • live attenuated japanese encephalitis vaccine sa14-14-2
  • live attenuated japanese encephalitis virus
  • live attenuated je vaccine
  • live attenuated sa 14-14-2 vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06680128Phase 1/Phase 2 (Phase 2)Feb 20, 2025SK Bioscience Co., Ltd.
NCT06825312Phase 4Nov 11, 2023Government of China, Liaoning Chengda
NCT05568953Phase 2Oct 31, 2022Duke University, Singapore General Hospital
NCT03920111N/AJul 1, 2019University of Liverpool
NCT03296410Phase 4Sep 14, 2017Chinese Academy of Medical Sciences, Government of China
NCT02933710Phase 4Oct 7, 2016Sanofi
NCT02492165Phase 3Jun 1, 2015Government of Vietnam, Sanofi, Sanofi-Aventis
NCT02526550Phase 4Jun 1, 2014Sanofi-Aventis, Siriraj Hospital
NCT02602652N/ADec 1, 2013Chulalongkorn University, Sanofi-Aventis
NCT01981967Phase 4Nov 1, 2013Sanofi, Sanofi-Aventis
NCT01900444Phase 3Jul 1, 2013Sanofi, Sanofi-Aventis
NCT01815073Phase 4Mar 1, 2013Changchun Keygen Biological Products Co., Ltd., Government of China
NCT01567865Phase 4May 1, 2012International Center for Diarrheal Disease Research, PATH
NCT01656200Phase 4May 1, 2012Indian Institute of Science, National Institute of Mental Health and Neuro Sciences, India, PATH, University of Liverpool, Wellcome Trust
NCT01396512Phase 3Jul 1, 2011Sanofi, Sanofi-Aventis
NCT01092507Phase 3Mar 1, 2010Sanofi
NCT00463684Phase 3Jul 1, 2007PATH, Sri Lanka Ministry of Healthcare and Nutrition
NCT00463476Phase 3Jul 1, 2007PATH, Sri Lanka Ministry of Healthcare and Nutrition
NCT00412516Phase 3Dec 1, 2006PATH
NCT00249769Phase 3Nov 1, 2005PATH
Showing 20 of 23 trials
Page 1 / 2

Organizations

Research & Development (19)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
SanofiFor profit9932003
PATHAcademic/Hospital6522005
Sanofi-AventisFor profit6032011
Government of ChinaGovernment3012013
Sri Lanka Ministry of Healthcare and NutritionGovernment2012007
University of LiverpoolAcademic/Hospital2122012
Changchun Keygen Biological Products Co., Ltd.For profit1112013
Chinese Academy of Medical SciencesAcademic/Hospital1112017
Chulalongkorn UniversityAcademic/Hospital1112013
Duke UniversityAcademic/Hospital1012022
Government of VietnamGovernment1012015
Indian Institute of ScienceAcademic/Hospital1112012
International Center for Diarrheal Disease ResearchAcademic/Hospital1012012
Liaoning ChengdaGovernment1112023
National Institute of Mental Health and Neuro Sciences, IndiaAcademic/Hospital1012012
Singapore General HospitalAcademic/Hospital1112022
Siriraj HospitalAcademic/Hospital1112014
SK Bioscience Co., Ltd.For profit1112025
Wellcome TrustAcademic/Hospital1012012
19 organizations
Page 1 / 1